Risk of myocardial infarction in psoriasis patients: A retrospective cohort study

Journal of Dermatological Treatment

Volumn 26, Issue 3, 2015, Pages 230-234

  Wu, Jashin J ^a   Choi, Young M ^b   Bebchuk, Judith D ^c  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Biologics; Cardiovascular; Inflammation

Indexed keywords

ADALIMUMAB; ALEFACEPT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; METHOXSALEN; USTEKINUMAB;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; COMPLICATION; MYOCARDIAL INFARCTION; RISK;

AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PSORIASIS; RETROSPECTIVE STUDIES; RISK;

EID: 84937904963     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2014.952609     Document Type: Article

References (16)

1. Channual J, Wu JJ, Dann FJ. Effects of TNF-alpha blockade on metabolic syndrome in psoriasis: lessons learned from rheumatoid arthritis and psoriatic arthritis. Dermatol Ther. 2009;22:61-73.
2. Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol. 2009;23:1311-15.
3. Lin HW, Wang KH, Lin HC, et al. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year populationbased study in Taiwan. J Am Acad Dermatol. 2011;64:495-501.
4. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;159:895-902.
5. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-41.
6. Maradit-Kremers H, Dierkhising RA, Crowson CS, et al. Risk and predictors of cardiovascular disease in psoriasis: a population-based study. Int J Dermatol. 2013;52:32-40.
7. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol. 2010;130:962-7.
8. Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol. 2010;24:885-92.
9. Brauchli YB, Jick SS, Miret M, et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009;160:1048-56.
10. Levesque A, Lachaine J, Bissonnette R. Risk of myocardial infarction in canadian patients with psoriasis: a retrospective cohort study. J Cutan Med Surg. 2013;17:398-403.
11. Wu JJ, Poon KT, Channual JC, Shen AY. Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis. Arch Dermatol. 2012;148: 1244-50.
12. Icen M, Crowson CS, McEvoy MT, et al. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol. 2008;59:981-5.
13. Asgari MM, Wu JJ, Gelfand JM, et al. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf. 2013;22: 842-9.
14. Wu JJ, Helen Black M, Smith N, et al. Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California. J Am Acad Dermatol. 2011;65:957-64.
15. Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149:1173-9.
16. Garcá-Diez A, Foraster CF, Sebastián FV, et al. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3, 300 patients in the Iberian region. Dermatology. 2008;216: 137-51.